Part D Spending on 10 Most Popular Medications Over Five Years Averages Five Times What Drug Companies Claim to Invest in R&D In case you missed it, AARP’s Public Policy Institute released a new analysis Wednesday examining Medicare Part D spending over a year five year period, from 2016 to 2020, on the 10 top-selling brand name
Another Round of Big Pharma Giants Beat Wall Street Expectations In Q1 After Hiking Prices Throughout Pandemic Big Pharma giants Bristol-Myers Squibb, Pfizer…
Lawmakers Should Focus Attention on Brand Name Drug Companies’ Egregious Practices, Recommit to Market-Based Solutions to Lower Drug Prices On Thursday, May 5, the U.S. Senate Committee on…
Big Pharma Giants Repeatedly Hike Prices and Continue to Beat Wall Street Expectations This week, Novartis, GlaxoSmithKline, Amgen, and Roche all reported earnings for the first quarter. All four…
Seven-Figure Campaign Calls on Lawmakers to Reject Big Pharma’s Blame Game and Deliver on Repeated Promises to Lower Prescription Drug Prices For Immediate Release Contact: Jon Conradi…
Patients for Affordable Drugs Now Poll Finds Vast Majority of Voters Reject Pharmaceutical Industry Rhetoric, Want Lawmakers to Hold Big Pharma Accountable A new national survey from Patients for…
J&J Beats Q1 Earnings Expectations, Announces Dividend Increase After Hiking Prices on Dozens of Brand Name Drugs This week, Johnson & Johnson kicked off the first round of Big Pharma…
Highlights How Administration and Lawmakers Can Fix Loopholes Exploited by Pharmaceutical Companies to Keep Drug Prices High A new editorial from The New York Times Editorial Board highlights how…
Decision Appropriately Balances Access to Treatment with the Need for More Data on the Clinical Value for Patients For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected]…
New Report Demonstrates How Brand Name Drug Companies Work in “Lockstep” to Hit Patients with Higher Prices on Life-Saving Medications In case you missed it…